Cancer Family
Gastric Neoplasm
CI-CAN-00000185Explore in graph →
Non-malignant718 active trials4 approved drugs55 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000185Explore in graph →
Clinical trials
3,260 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02967094 | Mucolytic Solution Before Upper Endoscopy | unknown | N/A | 150 | Vitkovice HospitalOTHER | 1 | Nov 29, 2016 | clinicaltrials |
| NCT02969148 | Laparoscopic Bursectomy and D2 Lymphadenectomy vs.Laparoscopic D2 Lymphadenectomy in Advanced Gastric Cancer(LBDL) | unknown | N/A | 100 | Guangdong Provincial Hospital of Traditional Chinese MedicineOTHER | 1 | Nov 21, 2016 |
| NCT02961296 | Helicobacter Pylori Antibiotic Susceptibility Testing of Korea | unknown | — | 400 | Asan Medical CenterOTHER | 1 | Nov 10, 2016 | clinicaltrials |
| NCT02949258 | Neoadjuvant Chemotherapy With SEEOX Regimen for Borrmann Type 4 Gastric Cancer(NCT-B4) | unknown | Phase 2 | 40 | Jinling Hospital, ChinaOTHER | 1 | Oct 31, 2016 | clinicaltrials |
| NCT01927328 | Iron Replacement in Oesophagogastric Neoplasia(IRON) | unknown | Phase 4 | 40 | Nottingham University Hospitals NHS TrustOTHER | 1 | Oct 28, 2016 | clinicaltrials |
| NCT02607826 | Short-term Starvation vs. Normal Diet Before Chemotherapy of Solid Tumors | unknown | N/A | 298 | University Hospital TuebingenOTHER | 0 | Oct 28, 2016 | clinicaltrials |
| NCT02833363 | Difference of Gastric Microbiota in the Process of Correa's Model. | unknown | — | 50 | Shandong UniversityOTHER | 1 | Oct 26, 2016 | clinicaltrials |
| NCT01456455 | Gastric Cancer Metastasized to the Central Nervous System (CNS) | unknown | — | 150 | University of ZurichOTHER | 1 | Oct 25, 2016 | clinicaltrials |
| NCT01795027 | Compare S-1 Plus Oxaliplatin to S-1 as Adjuvant Chemotherapy After D2 Resection in Patients With Gastric Cancer(CAPITAL) | unknown | Phase 3 | 724 | Sun Yat-sen UniversityOTHER | 1 | Oct 25, 2016 | clinicaltrials |
| NCT02873520 | Precision Cell Immunotherapy Combined With Chemotherapy in Advanced Gastric Cancer | unknown | Phase 1 / Phase 2 | 40 | Ningbo Cancer HospitalINDUSTRY | 1 | Oct 7, 2016 | clinicaltrials |
| NCT02915393 | System Biology of Spleen Deficiency Syndrome(SBSDS) | unknown | — | 90 | Beijing University of Chinese MedicineOTHER | 0 | Sep 27, 2016 | clinicaltrials |
| NCT01911832 | Impact of Gastric Tube Reconstruction Widths on Quality of Life for Esophagogastric Cancers | unknown | Phase 3 | 60 | West China HospitalOTHER | 1 | Sep 13, 2016 | clinicaltrials |
| NCT02644148 | Uncut Roux-en-Y Gastrojejunostomy for Early Gastric Cancer Patients | unknown | Phase 2 | 150 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Aug 11, 2016 | clinicaltrials |
| NCT02855788 | Metronomic Chemotherapy in Advanced Gastric Cancer | unknown | Phase 2 | 40 | Huashan HospitalOTHER | 2 | Aug 4, 2016 | clinicaltrials |
| NCT02537171 | Apatinib as Maintenance Therapy After First Line Treatment in Locally Advanced or Metastatic Gastric Cancer | unknown | Phase 3 | 40 | The Affiliated Hospital of the Chinese Academy of Military Medical SciencesOTHER | 1 | Aug 2, 2016 | clinicaltrials |
| NCT02529878 | Study of Convernsion Therapy Using S1/Paclitaxel Chemotherapy Plus Apatinib in Unresectable Gastric Cancer | unknown | Phase 2 | 30 | The First Affiliated Hospital of Zhejiang Chinese Medical UniversityOTHER | 1 | Jul 26, 2016 | clinicaltrials |
| NCT02843412 | The Clinical Study of Assessing HER-2 Expression in Gastric Cancer With Extra Tumor Tissue Paraffin Blocks Using Immunohistochemistry | unknown | — | 2,000 | Shanghai Zhongshan HospitalOTHER | 0 | Jul 25, 2016 | clinicaltrials |
| NCT02352571 | Safety Study of GC1118 (Recombinant Human Anti-EGFR Antibody) in Patients With Advanced Solid Cancer | unknown | Phase 1 | 72 | Green Cross CorporationINDUSTRY | 1 | Jul 6, 2016 | clinicaltrials |
| NCT02699047 | Fish Oil Supplementation in Gastrointestinal Cancer | unknown | N/A | 56 | Universidade Federal de Santa CatarinaOTHER | 1 | Jun 30, 2016 | clinicaltrials |
| NCT02817425 | A Efficacy and Tolerability Study of TEGAFOX Sequential S-1 in the Treatment of Adjuvant Chemotherapy for Gastric Cancer | unknown | Phase 2 / Phase 3 | 300 | LanZhou UniversityOTHER | 1 | Jun 29, 2016 | clinicaltrials |
| NCT01100801 | A Study of Genomic-guided 'Standard-of-care' Chemotherapy for in Advanced Gastric Cancer Patients(3G) | unknown | Phase 2 | 90 | National University Hospital, SingaporeOTHER | 1 | Jun 22, 2016 | clinicaltrials |
| NCT01227772 | Study of OTSGC-A24 Vaccine in Advanced Gastric Cancer | unknown | Phase 1 / Phase 2 | 23 | National University Hospital, SingaporeOTHER | 3 | Jun 22, 2016 | clinicaltrials |
| NCT01228045 | A Study of Trastuzumab in Combination With TS-ONE & Cisplatin in First-line Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric Cancer | unknown | Phase 2 | 30 | National University Hospital, SingaporeOTHER | 1 | Jun 22, 2016 | clinicaltrials |
| NCT01803503 | Docetaxel With or Without Low-dose, Short Course Sunitinib in Refractory Solid Tumors | unknown | Phase 2 | 80 | National University Hospital, SingaporeOTHER | 1 | Jun 22, 2016 | clinicaltrials |
| NCT02030561 | NK Cell Infusions With Trastuzumab for Patients With HER2+ Breast and Gastric Cancer | unknown | Phase 1 / Phase 2 | 29 | National University Hospital, SingaporeOTHER | 1 | Jun 22, 2016 | clinicaltrials |
| NCT02805829 | Combination Trastuzumab With Expanded Natural Killer Cells for Treating HER2-positive Gastric Cancer | unknown | Phase 1 / Phase 2 | 20 | Xuzhou Medical UniversityOTHER | 1 | Jun 22, 2016 | clinicaltrials |
| NCT02806661 | Comparison of Vagus Nerve-preserving RADG and Conventional RADG for AGC | unknown | N/A | 24 | Yingxue HaoOTHER | 1 | Jun 20, 2016 | clinicaltrials |
| NCT01542294 | SOX as Adjuvant Chemotherapy for Resectable Gastric Cancer | unknown | Phase 1 / Phase 2 | 71 | Chinese Academy of Medical SciencesOTHER | 1 | Jun 14, 2016 | clinicaltrials |
| NCT01739894 | Feasibility Study of Intraperitoneal Paclitaxel | unknown | Phase 2 | 20 | National University Hospital, SingaporeOTHER | 1 | Jun 7, 2016 | clinicaltrials |
| NCT02317471 | Immunotherapy of Gastric Cancer With Autologous Tumor Derived Heat Shock Protein gp96 | unknown | Phase 1 / Phase 2 | 45 | Chinese PLA General HospitalOTHER | 1 | Jun 6, 2016 | clinicaltrials |
| NCT02784470 | Study of Gastroduodenal Metallic Stent vs Gastrojejunostomy | unknown | Phase 3 | 92 | Asan Medical CenterOTHER | 1 | May 27, 2016 | clinicaltrials |
| NCT02215837 | Study of Autologous Tumor Lysate-pulsed D-CIK Combined With Chemotherapy for Gastric Cancer | unknown | Phase 2 | 40 | Shenzhen Hornetcorn Bio-technology Company, LTDINDUSTRY | 1 | May 24, 2016 | clinicaltrials |
| NCT02776527 | A Clinical Trial of Maintenance Treatment of Apatinib in Advanced Gastric Cancer Patients Have Completed Postoprative Adjuvant Chemotherapy | unknown | Phase 4 | 40 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | May 20, 2016 | clinicaltrials |
| NCT02756455 | Procalcitonin Reveals Early Dehiscence in Gastric Surgery: the PREDIGS Study | unknown | — | 100 | University of Roma La SapienzaOTHER | 1 | Apr 29, 2016 | clinicaltrials |
| NCT02144727 | A Clinical Trial of D1+ Versus D2 Distal Gastrectomy for Stage IB & II Advanced Gastric Cancer(ADDICT) | unknown | Phase 3 | 1,880 | National Cancer Center, KoreaOTHER_GOV | 1 | Apr 20, 2016 | clinicaltrials |
| NCT02572050 | Assessment of a Robotic Distal Gastrectomy on Non-inferiority of N2 Area Nodal Dissection(AaRon) | unknown | Phase 2 | 87 | National Cancer Center, KoreaOTHER_GOV | 1 | Apr 20, 2016 | clinicaltrials |
| NCT02457624 | Gastric Cancer Screening Quality Improvement System Establishment | unknown | — | 17 | Seoul National University HospitalOTHER | 1 | Apr 18, 2016 | clinicaltrials |
| NCT02388581 | First-line Antibiotic Therapy for Early-stage HP(+) Gastric Pure DLBCL | unknown | Phase 2 | 30 | National Health Research Institutes, TaiwanOTHER | 1 | Mar 25, 2016 | clinicaltrials |
| NCT02710838 | The Feasible Research of Infrared Endoscope to Diagnose Early Gastric Cancer | unknown | N/A | 40 | Xijing Hospital of Digestive DiseasesOTHER | 1 | Mar 22, 2016 | clinicaltrials |
| NCT02704299 | The Study of Surgery,Chemotherapy and Autologous T Cells-Based Immunotherapy for Advanced Gastric Cancer. | unknown | Early Phase 1 | 36 | Shanghai AbelZeta Ltd.INDUSTRY | 0 | Mar 11, 2016 | clinicaltrials |
| NCT01637805 | Clinical Safety and Preliminary Efficacy of AAV-DC-CTL Treatment in Stage IV Gastric Cancer(AAV-DC-CTL) | unknown | Phase 1 | 30 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Mar 8, 2016 | clinicaltrials |
| NCT01637350 | Digestive Tract Reconstruction After Gastrectomy of Gastric Cancer With Type 2 Diabetes | unknown | — | 60 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Feb 17, 2016 | clinicaltrials |
| NCT02674373 | Prognostic and Predictive Impact of Circulating Tumor DNA in Gastric Cancer Treatment(PLAGAST) | unknown | — | 200 | Association des Gastroentérologues OncologuesOTHER | 1 | Feb 4, 2016 | clinicaltrials |
| NCT02672774 | Novel Endoscopic Imaging Methods for the Evaluation of Blood Vessels in Gastrointestinal Cancers(IM-ANG) | unknown | N/A | 50 | University of Medicine and Pharmacy CraiovaOTHER | 1 | Feb 3, 2016 | clinicaltrials |
| NCT02668380 | An Open Label, Prospective, Multicentre, Non-interventional Study of Apatinib for Chemotherapy-Refractory Advanced Metastatic Gastric Cancer(AHEAD-G202) | unknown | — | 300 | Peking Union Medical College HospitalOTHER | 1 | Jan 29, 2016 | clinicaltrials |
| NCT02662959 | Irinotecan as 3rd Line Therapy in Gastric Cancer | unknown | Phase 2 | 93 | Fudan UniversityOTHER | 1 | Jan 26, 2016 | clinicaltrials |
| NCT02663427 | Serological Screening of Gastric Cancer in Wuxi Region | unknown | N/A | 5,000 | Wuxi People's HospitalOTHER | 0 | Jan 26, 2016 | clinicaltrials |
| NCT02662348 | T Cell Mediated Adaptive Therapy for Her2-positive Neoplasms of Digestive System | unknown | Phase 1 | 6 | Yi MiaoOTHER | 1 | Jan 25, 2016 | clinicaltrials |
| NCT02648841 | A Randomized Phase III Study of Adjuvant Chemotherapy With or Without Chemo-radiotherapy in Patients With Local Advanced Gastric Cancer After D2 Resection. | unknown | Phase 3 | 588 | Chinese Academy of Medical SciencesOTHER | 1 | Jan 7, 2016 | clinicaltrials |
| NCT02632201 | Immunotherapy Using Pluripotent Killer-Human Epidermal Growth Factor Receptor-2 (PIK-HER2) Cells for the Treatment of Advanced Gastric Cancer With Liver Metastasis | unknown | Phase 1 / Phase 2 | 40 | Second Military Medical UniversityOTHER | 1 | Jan 1, 2016 | clinicaltrials |
Data updated 23 days agoSource updated Nov 29, 2016source: clinicaltrials